HTLV, a multi organ oncovirus. (August 2022)
- Record Type:
- Journal Article
- Title:
- HTLV, a multi organ oncovirus. (August 2022)
- Main Title:
- HTLV, a multi organ oncovirus
- Authors:
- Ramezani, Samaneh
Rezaee, Seyed Abdolrahim
Farjami, Zahra
Ebrahimi, Neshat
Abdullabass, Hasaneen Kudhair
Ibrahim Jebur, Mohammad Ismael
Rafatpanah, Houshang
Akbarin, Mohammad Mehdi - Abstract:
- Abstract: Human T lymphotropic virus (HTLV-I) is a retrovirus that has been recognized as a causative agent of two crucidal diseases, HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T cell Leukemia-Lymphoma (ATLL). The virus not only induces those diseases in a small proportion of HTLV-I carriers (3–5%) but also it is associated with other diseases such as HTLV-I-Associated Arthropathy (HAAP), Cutaneous T Cell Lymphoma (CTCL), Graves' disease, uveitis, polymyositis, chronic respiratory diseases, lymphadenitis and dermatitis. Furthermore, HTLV related and accelerated disorders were more investigated, and the factors that might implicate in the development or progression of diseases have been discussed. We founded 13 categories of non-associated disease in studies such as Reproductive Disorders, Coronary Artery Disease (CAD), non –ATLL lymphoma, Co-infection, non-HAM/TSP neurological associated disease, non ATLL cutaneous associated disease, Autoimmune-Inflammatory related disease, Kidney disease, Liver disease, Respiratory disease, TB disease and Thyroid disease. With regard to the reviewed studies suggested HTLV-I disorders can divide into three manifests; related, accelerated and associated disease. However, interaction between HTLV-I infection and host immune response was complicated and vague. Some infectious patients indicated the involvement of inflammatory response of immune system, but in other individuals function of anti-inflammatoryAbstract: Human T lymphotropic virus (HTLV-I) is a retrovirus that has been recognized as a causative agent of two crucidal diseases, HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T cell Leukemia-Lymphoma (ATLL). The virus not only induces those diseases in a small proportion of HTLV-I carriers (3–5%) but also it is associated with other diseases such as HTLV-I-Associated Arthropathy (HAAP), Cutaneous T Cell Lymphoma (CTCL), Graves' disease, uveitis, polymyositis, chronic respiratory diseases, lymphadenitis and dermatitis. Furthermore, HTLV related and accelerated disorders were more investigated, and the factors that might implicate in the development or progression of diseases have been discussed. We founded 13 categories of non-associated disease in studies such as Reproductive Disorders, Coronary Artery Disease (CAD), non –ATLL lymphoma, Co-infection, non-HAM/TSP neurological associated disease, non ATLL cutaneous associated disease, Autoimmune-Inflammatory related disease, Kidney disease, Liver disease, Respiratory disease, TB disease and Thyroid disease. With regard to the reviewed studies suggested HTLV-I disorders can divide into three manifests; related, accelerated and associated disease. However, interaction between HTLV-I infection and host immune response was complicated and vague. Some infectious patients indicated the involvement of inflammatory response of immune system, but in other individuals function of anti-inflammatory elements was observed. For a better understanding of this classification, more systematic studies should be designed and need to provide a global network to control and prevent HTLV affiliated diseases. Highlights: HTLV-I is a causative agent of HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T cell Leukemia Lymphoma (ATLL). HTLV-I/II is associated HAAP, CTCL, Graves' disease, uveitis, polymyositis, chronic respiratory diseases, lymphadenitis and dermatitis. We founded 13 categories of non-associated disease in studies. HTLV-I disorders can divide into three manifests; related, accelerated and associated disease. Interaction between HTLV-I infection and host immune response was complicated. Some infectious patients indicated the inflammatory response, but another the anti-inflammatory response is main immune events. … (more)
- Is Part Of:
- Microbial pathogenesis. Volume 169(2022)
- Journal:
- Microbial pathogenesis
- Issue:
- Volume 169(2022)
- Issue Display:
- Volume 169, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 169
- Issue:
- 2022
- Issue Sort Value:
- 2022-0169-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-08
- Subjects:
- HTLV-I non-associated disease -- Carriers -- HAM/TSP -- ATLL
Pathogenic microorganisms -- Periodicals
Pathology, Molecular -- Periodicals
Communicable Diseases -- microbiology -- Periodicals
Communicable Diseases -- parasitology -- Periodicals
Micro-organismes pathogènes -- Périodiques
Pathologie moléculaire -- Périodiques
Electronic journals
616.9041 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08824010 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0882-4010;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.micpath.2022.105622 ↗
- Languages:
- English
- ISSNs:
- 0882-4010
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5756.955000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22765.xml